Replies to post #208345 on Bioelectronics Corp (BIEL)

[ddls]

Losses running 10-times sales. EPS is .00004

Figuring they make 1M in gross sales in 2019 and dividing that by 23 billion (i.e. shares) we get .00004. COOL!

https://backend.otcmarkets.com/otcapi/company/financial-report/235323/content

Declining Sales Cheers!

[GetSeriousOK]

stuffed pigs don't bleed.

And at this stage, BIEL doesn't lose much -- notably, they don't spend millions on clinical trials and they don't spend millions on loan interest.

They don't sell much either, of course. Still developmental. The FDA clearances they have don't amount to much. Unrestricted OTC is the BRASS RING.